Friedmund Neumann Prize 2018

A promising therapeutic option for metabolic disorders is the activation of brown adipose tissue. The biochemist and molecular biologist Dr. Alexander Bartelt, principal investigator at the Institute for Cardiovascular Prevention at the Ludwig-Maximilians-Universität (LMU) Munich, has developed and continually advanced this concept. In his young career, he has already been able to show that the activation of brown adipose tissue can significantly reduce harmful blood fats and sugars. Moreover, he has been able to identify new intracellular mechanisms that control the function and activity of brown adipose tissue.

• Press release
  
• Einladungskarte Preisverleihung 2018